Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2708 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-1 | 42013.5 | 38 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 41290.0 | 58 | |
| RA1869 | TNF-a | 100 | ng/mL | 1 | MMP-1 | 41053.5 | 36 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 40810.0 | 55 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-6 | 40558.5 | 70 | ||||
| N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 39896.0 | 47 | ||||
| RA1869 | JNK-IN-8 | 3.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 39832.5 | 34 | |
| RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 39325.0 | 58 | ||||
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-6 | 39158.5 | 78 | |
| RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-6 | 39085.0 | 83 | |
| N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-6 | 39011.0 | 63 | |
| N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 38913.5 | 58 | ||||
| RA2708 | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 38834.0 | 59 | ||||
| RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL-6 | 38834.0 | 79 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 38583.0 | 59 | ||||
| N2759 | IL-1 alpha | 100 | ng/mL | 3 | IL-6 | 38533.0 | 73 | ||||
| N2586 | Poly(I:C) | 2 | ug/mL | 1 | IL-6 | 38376.5 | 64 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL-6 | 38286.0 | 77 | ||||
| RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL-6 | 38263.0 | 63 | ||||
| N2586 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 38228.0 | 75 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL1-a | 38182.0 | 55 | |
| RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 38080.0 | 79 | |
| RA2708 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-6 | 38046.0 | 74 | |
| N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 38034.0 | 78 | ||||
| N2759 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-6 | 37964.0 | 49 |